- Qiagen NV
- Illumina Inc.
- Life Technologies Corp.
- Quest Diagnostics Inc.
- Laboratory Corp. of America Holdings
- Gen-Probe Inc.
- Genomic Health Inc.
- Myriad Genetics Inc.
- Clarient Inc.
- General Electric Co.
- GE Healthcare
- Genentech Inc.
- Siemens AG
- Beckman Coulter Inc.
- Becton Dickinson & Co.
- Abbott Laboratories Inc.
- Eli Lilly & Co.
- Biosite Inc.
- Alere Medical Inc.
- Hologic Inc.
- Chugai Pharmaceutical Co. Ltd.
- GlaxoSmithKline PLC
- Bayer AG
- Qiagen Manchester Ltd.
- Novartis AG
- Genoptix Inc.
- Novartis Molecular Diagnostics
- Avid Radiopharmaceuticals Inc.
- Pfizer Inc.
- Nestle SA
- Prometheus Laboratories Inc.
- Institute for Systems Biology
- Merck & Co. Inc.
- Bayer AG
- Bayer HealthCare Pharmaceuticals AG
- Agendia BV
- Roche to gain full ownership of Genentech in $43.7bn deal
- Siemens buys Bayer Diagnostics for €4.2bn
- Inverness Medical buys Biosite
- Invitrogen buys Applied Biosystems for $6.3bn
- Cytyc and Hologic to merge in $6.5bn deal
- Nippon Roche acquires majority of Chugai
- Siemens buys into clinical diagnostics in $7bn Dade takeover
- GE buys Abbott's POC, diagnostics units for $8bn; withdrawn
- Qiagen is paying $1.42bn for Digene
- LabCorp buys Monogram Biosciences for $107mm plus debt
- Qiagen buys DxS for $95mm plus earn-outs
- Novartis buys Genoptix for $440mm; Genoptix sold off
- GE to buy Clarient for $587mm
- Eli Lilly to buy Avid for $300mm up front plus earn-outs
- Abbott, GSK to develop diagnostic for NSCLC
- GSK signs second MAGE-A3 collaboration with Abbott Molecular
- Nestle boosts personalized nutritionals initiative with Prometheus buy
- Merck & Co. acquires Rosetta Inpharmatics
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.